Longeveron, Inc. (LGVN)
Longeveron Market Cap : 36.75M for April 7, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Acadia Healthcare Co., Inc. | 2.386B |
| Charles River Laboratories International, Inc. | 8.418B |
| BioRestorative Therapies, Inc. | 6.364M |
| Fate Therapeutics, Inc. | 130.33M |
| CytomX Therapeutics, Inc. | 907.38M |
Market Cap Related Metrics
| PS Ratio | 18.65 |
| Price to Book Value | 6.475 |
| Price | 1.16 |
| Earnings Yield | -103.6% |